Promoter methylation of O6-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53

Ji Ching Lai, Ya Wen Cheng, Yih Gang Goan, Jinghua Tsai Chang, Tzu Chin Wu, Chih Yi Chen, Huei Lee

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Methylation of the O6-methylguanine-DNA-methyltransferase (MGMT) promoter is associated with G:C to A:T transitions in the p53 gene in various human cancers, including lung cancer. In tumors with p53 mutation, MGMT promoter methylation is more common in advanced tumors than in early tumors. However, in tumors with wild-type p53, MGMT promoter methylation is independent of tumor stage. To elucidate whether p53 participates in MGMT promoter methylation, we engineered three cell models: A549 cells with RNA interference (RNAi)-mediated knockdown of p53, and p53 null H1299 cells transfected with either wild-type p53 (WT-p53) or mutant-p53 (L194R, and R249S-p53). Knockdown of endogenous p53 increased MGMT promoter methylation in A549 cells, and transient expression of WT-p53 in p53 null H1299 cells diminished MGMT promoter methylation, whereas the MGMT promoter methylation status were unchanged by expression of mutant-p53. Previous work showed that p53 modulates DNA-methyltransferase 1 (DNMT1) expression; we additionally examined chromatin remodeling proteins expression levels of histone deacetylase 1 (HDAC1). We found that p53 knockdown elevated expression of both DNMT1 and HDAC1 in A549 cells. Conversely, expressing WT-p53 in p53 null H1299 cells reduced DNMT1 and HDAC1 expression, but the reduction of both proteins was not observed in expressing mutant-p53 H1299 cells. CHIP analysis further showed that DNMT1 and HDAC1 binding to the MGMT promoter was increased by MGMT promoter methylation and decreased by MGMT promoter demethylation. In conclusion, MGMT promoter methylation modulated by p53 status could partially promote p53 mutation occurrence in advanced lung tumors.

Original languageEnglish
Pages (from-to)1352-1363
Number of pages12
JournalDNA Repair
Volume7
Issue number8
DOIs
Publication statusPublished - Aug 2 2008
Externally publishedYes

Fingerprint

Methylation
Methyltransferases
Lung Neoplasms
DNA
Histone Deacetylase 1
Tumors
Null Lymphocytes
Neoplasms
O-(6)-methylguanine
Mutation
Chromatin Assembly and Disassembly
p53 Genes
RNA Interference
Chromatin

Keywords

  • Lung cancer
  • O-Methylguanine-DNA-methyltransferase
  • p53 Mutation
  • Promoter methylation

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Lai, J. C., Cheng, Y. W., Goan, Y. G., Chang, J. T., Wu, T. C., Chen, C. Y., & Lee, H. (2008). Promoter methylation of O6-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53. DNA Repair, 7(8), 1352-1363. https://doi.org/10.1016/j.dnarep.2008.04.016

Promoter methylation of O6-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53. / Lai, Ji Ching; Cheng, Ya Wen; Goan, Yih Gang; Chang, Jinghua Tsai; Wu, Tzu Chin; Chen, Chih Yi; Lee, Huei.

In: DNA Repair, Vol. 7, No. 8, 02.08.2008, p. 1352-1363.

Research output: Contribution to journalArticle

Lai, JC, Cheng, YW, Goan, YG, Chang, JT, Wu, TC, Chen, CY & Lee, H 2008, 'Promoter methylation of O6-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53', DNA Repair, vol. 7, no. 8, pp. 1352-1363. https://doi.org/10.1016/j.dnarep.2008.04.016
Lai, Ji Ching ; Cheng, Ya Wen ; Goan, Yih Gang ; Chang, Jinghua Tsai ; Wu, Tzu Chin ; Chen, Chih Yi ; Lee, Huei. / Promoter methylation of O6-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53. In: DNA Repair. 2008 ; Vol. 7, No. 8. pp. 1352-1363.
@article{d2a085ccafcf412f81186fad9ec4150a,
title = "Promoter methylation of O6-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53",
abstract = "Methylation of the O6-methylguanine-DNA-methyltransferase (MGMT) promoter is associated with G:C to A:T transitions in the p53 gene in various human cancers, including lung cancer. In tumors with p53 mutation, MGMT promoter methylation is more common in advanced tumors than in early tumors. However, in tumors with wild-type p53, MGMT promoter methylation is independent of tumor stage. To elucidate whether p53 participates in MGMT promoter methylation, we engineered three cell models: A549 cells with RNA interference (RNAi)-mediated knockdown of p53, and p53 null H1299 cells transfected with either wild-type p53 (WT-p53) or mutant-p53 (L194R, and R249S-p53). Knockdown of endogenous p53 increased MGMT promoter methylation in A549 cells, and transient expression of WT-p53 in p53 null H1299 cells diminished MGMT promoter methylation, whereas the MGMT promoter methylation status were unchanged by expression of mutant-p53. Previous work showed that p53 modulates DNA-methyltransferase 1 (DNMT1) expression; we additionally examined chromatin remodeling proteins expression levels of histone deacetylase 1 (HDAC1). We found that p53 knockdown elevated expression of both DNMT1 and HDAC1 in A549 cells. Conversely, expressing WT-p53 in p53 null H1299 cells reduced DNMT1 and HDAC1 expression, but the reduction of both proteins was not observed in expressing mutant-p53 H1299 cells. CHIP analysis further showed that DNMT1 and HDAC1 binding to the MGMT promoter was increased by MGMT promoter methylation and decreased by MGMT promoter demethylation. In conclusion, MGMT promoter methylation modulated by p53 status could partially promote p53 mutation occurrence in advanced lung tumors.",
keywords = "Lung cancer, O-Methylguanine-DNA-methyltransferase, p53 Mutation, Promoter methylation",
author = "Lai, {Ji Ching} and Cheng, {Ya Wen} and Goan, {Yih Gang} and Chang, {Jinghua Tsai} and Wu, {Tzu Chin} and Chen, {Chih Yi} and Huei Lee",
year = "2008",
month = "8",
day = "2",
doi = "10.1016/j.dnarep.2008.04.016",
language = "English",
volume = "7",
pages = "1352--1363",
journal = "DNA Repair",
issn = "1568-7864",
publisher = "Elsevier",
number = "8",

}

TY - JOUR

T1 - Promoter methylation of O6-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53

AU - Lai, Ji Ching

AU - Cheng, Ya Wen

AU - Goan, Yih Gang

AU - Chang, Jinghua Tsai

AU - Wu, Tzu Chin

AU - Chen, Chih Yi

AU - Lee, Huei

PY - 2008/8/2

Y1 - 2008/8/2

N2 - Methylation of the O6-methylguanine-DNA-methyltransferase (MGMT) promoter is associated with G:C to A:T transitions in the p53 gene in various human cancers, including lung cancer. In tumors with p53 mutation, MGMT promoter methylation is more common in advanced tumors than in early tumors. However, in tumors with wild-type p53, MGMT promoter methylation is independent of tumor stage. To elucidate whether p53 participates in MGMT promoter methylation, we engineered three cell models: A549 cells with RNA interference (RNAi)-mediated knockdown of p53, and p53 null H1299 cells transfected with either wild-type p53 (WT-p53) or mutant-p53 (L194R, and R249S-p53). Knockdown of endogenous p53 increased MGMT promoter methylation in A549 cells, and transient expression of WT-p53 in p53 null H1299 cells diminished MGMT promoter methylation, whereas the MGMT promoter methylation status were unchanged by expression of mutant-p53. Previous work showed that p53 modulates DNA-methyltransferase 1 (DNMT1) expression; we additionally examined chromatin remodeling proteins expression levels of histone deacetylase 1 (HDAC1). We found that p53 knockdown elevated expression of both DNMT1 and HDAC1 in A549 cells. Conversely, expressing WT-p53 in p53 null H1299 cells reduced DNMT1 and HDAC1 expression, but the reduction of both proteins was not observed in expressing mutant-p53 H1299 cells. CHIP analysis further showed that DNMT1 and HDAC1 binding to the MGMT promoter was increased by MGMT promoter methylation and decreased by MGMT promoter demethylation. In conclusion, MGMT promoter methylation modulated by p53 status could partially promote p53 mutation occurrence in advanced lung tumors.

AB - Methylation of the O6-methylguanine-DNA-methyltransferase (MGMT) promoter is associated with G:C to A:T transitions in the p53 gene in various human cancers, including lung cancer. In tumors with p53 mutation, MGMT promoter methylation is more common in advanced tumors than in early tumors. However, in tumors with wild-type p53, MGMT promoter methylation is independent of tumor stage. To elucidate whether p53 participates in MGMT promoter methylation, we engineered three cell models: A549 cells with RNA interference (RNAi)-mediated knockdown of p53, and p53 null H1299 cells transfected with either wild-type p53 (WT-p53) or mutant-p53 (L194R, and R249S-p53). Knockdown of endogenous p53 increased MGMT promoter methylation in A549 cells, and transient expression of WT-p53 in p53 null H1299 cells diminished MGMT promoter methylation, whereas the MGMT promoter methylation status were unchanged by expression of mutant-p53. Previous work showed that p53 modulates DNA-methyltransferase 1 (DNMT1) expression; we additionally examined chromatin remodeling proteins expression levels of histone deacetylase 1 (HDAC1). We found that p53 knockdown elevated expression of both DNMT1 and HDAC1 in A549 cells. Conversely, expressing WT-p53 in p53 null H1299 cells reduced DNMT1 and HDAC1 expression, but the reduction of both proteins was not observed in expressing mutant-p53 H1299 cells. CHIP analysis further showed that DNMT1 and HDAC1 binding to the MGMT promoter was increased by MGMT promoter methylation and decreased by MGMT promoter demethylation. In conclusion, MGMT promoter methylation modulated by p53 status could partially promote p53 mutation occurrence in advanced lung tumors.

KW - Lung cancer

KW - O-Methylguanine-DNA-methyltransferase

KW - p53 Mutation

KW - Promoter methylation

UR - http://www.scopus.com/inward/record.url?scp=46649117841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46649117841&partnerID=8YFLogxK

U2 - 10.1016/j.dnarep.2008.04.016

DO - 10.1016/j.dnarep.2008.04.016

M3 - Article

C2 - 18555750

AN - SCOPUS:46649117841

VL - 7

SP - 1352

EP - 1363

JO - DNA Repair

JF - DNA Repair

SN - 1568-7864

IS - 8

ER -